These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 964342)

  • 21. Interactions of narcotics, narcotic antagonists, and ethanol during acute, chronic, and withdrawal states.
    Ho AK; Chen RC
    Ann N Y Acad Sci; 1976; 281():297-310. PubMed ID: 1071365
    [No Abstract]   [Full Text] [Related]  

  • 22. The structure-action relationship and kinetics of some naloxone and naltrexone derivatives.
    Vizi ES; Foldes FF; Rich J; Knoll J
    Pharmacology; 1976; 14(1):76-85. PubMed ID: 959310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Limitations on the antagonistic actions of opioid antagonists.
    Young AM; Woods JH
    Fed Proc; 1982 May; 41(7):2333-8. PubMed ID: 7042396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential antagonism by naltrexone of the effects of opioids on a fixed-ratio discrimination in rats.
    Moerschbaecher JM; Devia C; Brocklehurst C
    J Pharmacol Exp Ther; 1988 Jan; 244(1):237-46. PubMed ID: 3336001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute effects of opiate agonists, partial agonists and antagonists on brain monoamines in the rat.
    Fennessy MR; Laska FJ
    Arch Int Pharmacodyn Ther; 1979 Mar; 238(1):60-70. PubMed ID: 485705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxilorphan (l-N-cyclopropylmethyl-3,14-dihydroxymorphinan): a new synthetic narcotic antagonist.
    Pircio AW; Gylys JA
    J Pharmacol Exp Ther; 1975 Apr; 193(1):23-34. PubMed ID: 237112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of neurotrophic activity in salamanders treated with opioids.
    Smith AA; Hui F
    Exp Neurol; 1973 Apr; 39(1):36-43. PubMed ID: 4698586
    [No Abstract]   [Full Text] [Related]  

  • 28. Interaction between naltrexone and oral THC in heavy marijuana smokers.
    Haney M; Bisaga A; Foltin RW
    Psychopharmacology (Berl); 2003 Feb; 166(1):77-85. PubMed ID: 12491025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies of EN-1639A (naltrexone): a new narcotic antagonist.
    Resnick RB; Volavka J; Freedman AM; Thomas M
    Am J Psychiatry; 1974 Jun; 131(6):646-50. PubMed ID: 4827793
    [No Abstract]   [Full Text] [Related]  

  • 30. [DYNAMICS OF CHANGES OF THE NUCLEIC ACID CONTENT FOLLOWING ROENTGEN-IRRADIATION AND DEPRESSION AND RESTORATION OF REGENERATIVE CAPACITIES OF AXOLOTL EXTREMITIES].
    TEPLITS NA
    Dokl Akad Nauk SSSR; 1964 Jun; 156():1207-9. PubMed ID: 14219603
    [No Abstract]   [Full Text] [Related]  

  • 31. Inhibition of writhing by narcotic antagonists.
    Pearl J; Harris LS
    J Pharmacol Exp Ther; 1966 Nov; 154(2):319-23. PubMed ID: 4380744
    [No Abstract]   [Full Text] [Related]  

  • 32. Methadone ameliorates multiple-low-dose streptozotocin-induced type 1 diabetes in mice.
    Amirshahrokhi K; Dehpour AR; Hadjati J; Sotoudeh M; Ghazi-Khansari M
    Toxicol Appl Pharmacol; 2008 Oct; 232(1):119-24. PubMed ID: 18671992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opioid antagonism of cannabinoid effects: differences between marijuana smokers and nonmarijuana smokers.
    Haney M
    Neuropsychopharmacology; 2007 Jun; 32(6):1391-403. PubMed ID: 17091128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interactions between narcotic agonists, partial agonists and antagonists evaluated by schedule-controlled behavior.
    Harris RA
    J Pharmacol Exp Ther; 1980 Jun; 213(3):497-503. PubMed ID: 6110766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulatory effects of cyclazocine. A non-narcotic analgesic.
    Witherspoon CD; Montaner CG; Rusy BF
    Anesth Analg; 1966; 45(2):176-8. PubMed ID: 5949074
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical treatment of opioid addiction and dependence.
    Ling W; Rawson RA; Compton M
    Methods Mol Med; 2003; 84():285-95. PubMed ID: 12703332
    [No Abstract]   [Full Text] [Related]  

  • 37. Acetazolamide does not disrupt limb regenerate morphogenesis in the salamander, Plethodon cinereus.
    Dinsmore CE; Maren TH
    Teratology; 1986 Feb; 33(1):85-91. PubMed ID: 3738812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blocking endogenous opioids during development--do we understand the consequences?
    White J
    Addiction; 2013 Feb; 108(2):251-2. PubMed ID: 23331878
    [No Abstract]   [Full Text] [Related]  

  • 39. Long-acting narcotic antagonist complexes.
    Gray AP; Guardina WJ
    Natl Inst Drug Abuse Res Monogr Ser; 1975; (4):21-6. PubMed ID: 1234981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ethylketocyclazocine and bremazocine analgesia in neonatal rats.
    Helmstetter FJ; Calcagnetti DJ; Cramer CP; Fanselow MS
    Pharmacol Biochem Behav; 1988 Aug; 30(4):817-21. PubMed ID: 3067243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.